TipRanks
Newron Pharmaceuticals SpA (DE:NP5)
XETRA:NP5
Germany Market

Newron Pharmaceuticals SpA (NP5) Cash flow

3 Followers

Newron Pharmaceuticals SpA Cash Flow

DE:NP5's free cash flow for Q2 2026 was €-10.73M. For the 2026 fiscal year, DE:NP5's free cash flow was decreased by €50.14M and operating cash flow was €-10.71M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ 32.56M€ -17.61M€ -10.14M€ -11.09M€ -11.45M
Investing Cash Flow
€ -13.75M€ 3.16M€ 3.25M€ -317.00K€ 8.42M
Financing Cash Flow
€ -13.52M€ 15.05M€ -192.00K€ -186.00K€ 14.83M
End Cash Position
€ 12.18M€ 6.93M€ 6.34M€ 13.42M€ 25.02M
Free Cash Flow
€ 32.51M€ -17.63M€ -10.15M€ -11.11M€ -11.46M
Currency in EUR

Newron Pharmaceuticals SpA Cash Flow